That conversation is worth having with a clinician who can evaluate your individual picture
However, if the A1c is 60 mg/mmol, or progressive increase in UACR despite appropriate therapy, eGFR 30% increase in serum creatinine within 3 months of starting SGLT2i, ACEi, or ARB, inability to achieve target BP, or signs/symptoms of another underlying kidney disease, such as glomerulonephritis
Now. At Alpha Labs, I mention how being enclosed in the pods made me anxious
[Business Group on Health research shows] 73% of employers planned to cover GLP-1s to treat obesity in 2026
It activates the same GLP-1 pathway semaglutide uses, but it also targets glucose-dependent insulinotropic polypeptide (GIP) receptors